Predictive simulation in Pharma Production
Inosim Foresight brings simulation into operations, unlocking capacity, improving reliability, driving smarter decisions.
From complexity to predictive transparency
Pharmaceutical and biotech production environments are highly complex systems. Multi-product portfolios, interdependent processes and manual interventions must be managed under strict regulatory requirements and increasing pressure for efficiency. In many facilities, this results in conservative planning strategies that ensure delivery reliability, while leaving significant capacity unused.
With the integration of INOSIM Foresight into its digital solutions portfolio, ZETA is addressing this challenge by bringing predictive decision support into daily operations. By combining simulation-based digital twins with real-time data from existing IT and OT systems, ZETA and INOSIM enable a shift from reactive to proactive production management.
At the core of this approach lies a dynamic digital twin that continuously reflects both the current state of the plant and its expected future behavior. This creates a new level of transparency and allows production teams to make decisions based on reliable forecasts instead of assumptions.
Unlocking capacity and supporting operational decisions
One of the key advantages is the ability to overcome conservative planning practices. Predictive simulation evaluates all relevant constraints simultaneously - such as equipment availability, material flows and staffing requirements - enabling production plans that are both realistic and significantly more efficient. Hidden capacity can thus be unlocked without any physical expansion of the plant.
The value of this approach becomes even clearer during ongoing operations. Unplanned events such as equipment failures or resource shortages are detected in real time, and their impact on production schedules is immediately assessed. This allows teams to adjust plans quickly and prevent minor deviations from escalating into major production losses.
ZETA and INOSIM also provide tailored insights for all stakeholders. Operators receive clear guidance on manual tasks, improving execution on the shop floor. Production planners can better assess the feasibility of schedules and respond flexibly to changing requirements. At the same time, management benefits from predictive KPIs and aggregated dashboards that enable proactive decision-making.
Measurable impact and lifecycle optimization
In practice, this leads to measurable improvements. Production capacity can be increased significantly (often by 10–15%) without expanding existing facilities. Planning processes become faster and more efficient, while improved transparency reduces onboarding effort and enhances operational stability.
Beyond production planning, predictive decision support opens up further optimization potential across the lifecycle of a facility. Maintenance activities can be dynamically integrated into running production, reducing downtime and improving overall performance. At the same time, predictive insights enable more reliable delivery commitments and support data-driven decisions at both operational and strategic levels.
As pharmaceutical manufacturing evolves towards more flexible and data-driven operations, anticipating developments rather than reacting to them is emerging as a key competitive advantage. By integrating simulation directly into live operations, ZETA and INOSIM transform complex production environments into transparent, responsive systems, where decisions are based on data-driven foresight rather than assumptions.
Contact
Peer Sander, Head of Technical Affairs
Inosim GmbH
Photo: Inosim
